Unknown

Dataset Information

0

Novel stereoselective syntheses of N-octyl-β-valienamine (NOV) and N-octyl-4-epi-β-valienamine (NOEV) from (-)-shikimic acid.


ABSTRACT: N-Octyl-β-valienamine (NOV) 1 and N-octyl-4-epi-β-valienamine (NOEV) 2 are potent chemical chaperone drug candidates for the therapy of lysosomal storage disorders. Novel stereoselective syntheses of NOV 1 and NOEV 2 starting from naturally abundant (-)-shikimic acid are described in this article. The common key intermediate compound 5 was first synthesized from readily available (-)-shikimic acid via 9 steps in 50% yield. Compound 5 was then converted to NOV 1via 5 steps in 61% yield, and it was also converted to NOEV 2via 8 steps in 38% yield. In summary, NOV 1 was synthesized via 14 steps in 31% overall yield; and NOEV 2 was synthesized via 17 steps in 19% overall yield.

SUBMITTER: Li FL 

PROVIDER: S-EPMC9076550 | biostudies-literature | 2019 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Novel stereoselective syntheses of <i>N</i>-octyl-β-valienamine (NOV) and <i>N</i>-octyl-4-<i>epi</i>-β-valienamine (NOEV) from (-)-shikimic acid.

Li Feng-Lei FL   Yu Jiang-Ping JP   Ding Wei W   Sun Mian-Mian MM   He Yun-Gang YG   Zhu Xing-Liang XL   Liu Shi-Ling SL   Shi Xiao-Xin XX  

RSC advances 20191218 72


<i>N</i>-Octyl-β-valienamine (NOV) 1 and <i>N</i>-octyl-4-<i>epi</i>-β-valienamine (NOEV) 2 are potent chemical chaperone drug candidates for the therapy of lysosomal storage disorders. Novel stereoselective syntheses of NOV 1 and NOEV 2 starting from naturally abundant (-)-shikimic acid are described in this article. The common key intermediate compound 5 was first synthesized from readily available (-)-shikimic acid <i>via</i> 9 steps in 50% yield. Compound 5 was then converted to NOV 1<i>via<  ...[more]

Similar Datasets

| S-EPMC8264934 | biostudies-literature
| S-EPMC7614226 | biostudies-literature
| S-EPMC7003206 | biostudies-literature
| S-EPMC3515248 | biostudies-literature
| S-EPMC5315221 | biostudies-literature
| S-EPMC7545439 | biostudies-literature
| S-EPMC9026245 | biostudies-literature
| S-EPMC9066425 | biostudies-literature
| S-EPMC7961859 | biostudies-literature
| S-EPMC6962123 | biostudies-literature